Neurology Alert (Vol. 36, No. 2) - October 1, 2016

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: October 2016

Valid through: October 2019

Target Audience

This activity is intended for the neurologist.


  • Cancer in Autoimmune Necrotizing Myositis
  • Functional Outcomes in Acute Ischemic Stroke Patients Receiving Prehospital Thrombolysis in Mobile Stroke Units
  • Disease Rebound After Stopping Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis
  • Zika Virus Infection and Guillain-Barré Syndrome
  • Headaches in the Elderly: A Non-specific Marker for Stroke Risk Objectives


  • Discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • Discuss the pathogenesis and treatment of pain
  • Describe the basic science of brain function
  • Discuss new information regarding new drugs for commonly diagnosed neurological conditions

Credit Available


  • Maximum of 2.25 AMA PRA Category 1 Credits


This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation


AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing


Michael Rubin, MD, Professor of Clinical Neurology, Weill Cornell Medical College

Michael P. Lerario, MD, Assistant Professor of Clinical Neurology, Weill Cornell Medical College; Attending Physician, New York-Presbyterian Queens Hospital; and Medical Director of the New York-Presbyterian Mobile Stroke Unit

Jai S. Perumal, MD, Assistant Professor of Neurology, Weill Cornell Medical College

Joseph E. Safdieh, MD, Vice Chair and Associate Professor, Weill Cornell Medical College

Dara Jamieson, MD, Associate Professor of Clinical Neurology, Weill Cornell Medical College


Medical Editor: Matthew E. Fink, MD, Louis and Gertrude Feil Professor in Clinical Neurology, Chairman, Department of Neurology, Weill Cornell Medical College, Neurologist-in-Chief, New York Presbyterian Hospital

AHC Media Executive Editor: Leslie G. Coplin

Managing Editor: Jonathan Springston

Financial Disclosure

Author Jai S. Perumal, MD, reports she receives grant/research support from Genzyme Corp., and is on the speakers bureau for Biogen Idec, Genzyme Corp., Acorda Therapeutics, and Teva Pharmaceuticals. Dara Jamieson, MD, consultant for Bayer and Boehringer-Ingelheim

Authors Michael Rubin, MD, Michael P. Lerario, MD; and Joseph E. Safdieh, MD report no financial relationships relevant to this field of study.

Neurology Alert's editor in chief, Matthew E. Fink, MD reports he is a retained consultant for Procter & Gamble and Pfizer. Peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and associate managing editor Jonathan Springston report no financial relationships relevant to this field of study.

Copyright 2016, AHC Media. All rights reserved.